Ranatuerin-2Pb (1-32)

General Information


DCTPep ID  DCTPep03849

Peptide Name   Ranatuerin-2Pb (1-32)

Sequence  SFLTTVKKLVTNLAALAGTVIDTIKCKVTGGC

Sequence Length  32

UniProt ID  A9CBH5 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer therapy related peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available



Structure Information


PDB ID  Not available

Predicted Structure  Not available

(Please note that there is the predicted structure, predicted by AlphaFold)

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  Cys26<--->Cys32

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C145H253N37O43S2

Absent amino acids  EHMPQRWY

Theoretical pI  9.30

Acidic residues  1

Basic residues  4

Polar residues  13

Molecular weight (Average)  3266.95

Molecular weight (Monoisotopic)  3264.82

Common amino acids  T

Net charge  3

Instability index (II)  -15.32

Aliphatic index  118.75

Grand average of hydropathicity (GRAVY)  0.794

Half Life 
  1.9 hours (mammalian reticulocytes, in vitro).
  >20 hours (yeast, in vivo).
  >10 hours (Escherichia coli, in vivo).

Extinction coefficients 
  Ext. coefficient 125
  Abs 0.1% (=1 g/l) 0.038, assuming all pairs of Cys residues form cystines
  Ext. coefficient 0
  Abs 0.1% (=1 g/l) 0.000, assuming all Cys residues are reduced

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 31242693

Title  Bioevaluation of Ranatuerin-2Pb from the Frog Skin Secretion of Rana pipiens and its Truncated Analogues

Doi Not available

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  13625

DCTPep is developed by Dr.Zheng's team.